Tilray Brands (TLRY) Long-Term Investments (2019 - 2026)
Tilray Brands (TLRY) reported Long-Term Investments of $4.4 million for Q1 2026, down 67.42% quarter-over-quarter from $13.4 million in Q4 2025.
Tilray Brands (TLRY) Long-Term Investments (2019 - 2026) Analysis & Trends
Tilray Brands has reported Long-Term Investments for 8 years, with the latest figure at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Feb 2026 stood at $4.4 million (changed N/A YoY), and the FY2025 full-year result was $8.2 million, up 3.83% from the prior year.
- Long-Term Investments for Q1 2026 stood at $4.4 million, down from $13.4 million in the prior quarter.
- The five-year high for Long-Term Investments was $133.2 million in Q1 2022, with the low at $4.4 million in Q1 2026.
- Historically, Long-Term Investments has averaged $15.9 million across 5 years, with a median of $7.9 million in 2024.
- Annual changes were most pronounced in 2022 — Long-Term Investments sank 97.24% — and 2025, when it soared 80.6%.
- Tilray Brands' Long-Term Investments stood at $4.6 million in 2022, then surged by 73.22% to $8.0 million in 2023, then slipped by 7.69% to $7.4 million in 2024, then soared by 80.6% to $13.4 million in 2025, then sank by 67.42% to $4.4 million in 2026.
- The last three Long-Term Investments figures came in at $4.4 million (Q1 2026), $13.4 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 4.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 4.36 Mn |
| Nov 30, 2025 | 13.39 Mn |
| Aug 31, 2025 | 10.17 Mn |
| May 31, 2025 | 8.16 Mn |
| Nov 30, 2024 | 7.42 Mn |
| Aug 31, 2024 | 7.85 Mn |
| May 31, 2024 | 7.86 Mn |
| Nov 30, 2023 | 8.03 Mn |
| Aug 31, 2023 | 4.64 Mn |
| May 31, 2023 | 4.58 Mn |
| Feb 28, 2023 | 4.64 Mn |
| Nov 30, 2022 | 4.64 Mn |
| Aug 31, 2022 | 8.88 Mn |
| May 31, 2022 | 10.05 Mn |
| Feb 28, 2022 | 133.16 Mn |
| Nov 30, 2021 | 168.24 Mn |
| Aug 31, 2021 | 10.11 Mn |
| May 31, 2021 | 17.69 Mn |
| May 31, 2020 | 19.60 Mn |
| Dec 31, 2019 | 4.18 Mn |